| |
| |
|
| Insider
Information: |
Vogt Frederick G |
| Relationship: |
Interim CEO & General ... |
| City: |
West Norriton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
192,262 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,778,424 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
192,262 |
|
|
| Total
Value |
$1,778,424 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 5.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iovance Biotherapeutics Inc |
IOVA |
Interim CEO & General ... |
2024-09-03 |
192,262 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2022-06-01 |
4 |
B |
$6.44 |
$6,440 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2022-11-28 |
4 |
B |
$5.98 |
$5,980 |
D/D |
1,000 |
2,000 |
2.74 |
% |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-01-17 |
4 |
D |
$6.43 |
$234,316 |
D/D |
(36,441) |
48,884 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-01-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
83,325 |
85,325 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-04-14 |
4 |
D |
$5.64 |
$49,920 |
D/D |
(8,851) |
60,867 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,834 |
69,718 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-07-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,834 |
81,701 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-07-14 |
4 |
D |
$7.76 |
$68,684 |
D/D |
(8,851) |
72,850 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-10-16 |
4 |
D |
$3.57 |
$31,598 |
D/D |
(8,851) |
84,834 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2023-10-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,835 |
93,685 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-01-16 |
4 |
D |
$8.37 |
$54,656 |
D/D |
(6,530) |
99,138 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-01-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,834 |
105,668 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
41,662 |
140,800 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-03-04 |
4 |
D |
$16.96 |
$194,175 |
D/D |
(11,449) |
129,351 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-04-15 |
4 |
D |
$11.89 |
$105,238 |
D/D |
(8,851) |
141,334 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,834 |
150,185 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-06-03 |
4 |
D |
$8.37 |
$37,046 |
D/D |
(4,426) |
147,325 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,417 |
151,751 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-07-15 |
4 |
D |
$8.68 |
$76,827 |
D/D |
(8,851) |
159,309 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• – – |
2024-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,835 |
168,160 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• • – |
2024-09-03 |
4 |
D |
$10.85 |
$264,078 |
D/D |
(24,339) |
192,262 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
Interim CEO & General Counsel |
• • – |
2024-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
57,292 |
212,175 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
